Headquartered in Nottingham, UK, Phenna Group's aim is to invest in and partner with selected niche, independent Testing, Inspection, Certification and Compliance (TICC) companies that serve a variety of sectors, ensuring customers' peace of mind by delivering first class assurance services. This acquisition augments our fast growing Health Sciences platform and adds geographical and service extension to our growing market position.
Founded in 2004, Zeta Analytical’s core focus is on the provision of support for organisations in the pharmaceutical industry, offering solutions for their finished products that require further batch certification, as well as testing for finished product stability testing, raw materials, unlicensed medicines, veterinary medicines and nutritional veterinary products. The Company operates from a state-of-the-art, fully equipped laboratory in Watford, UK, which benefits from access to an extensive array of specialist equipment designed to support efficient, reliable physical and chemical testing for most requirements. By providing a consistently high standard of service, the Company has maintained an excellent reputation and long-standing international client relationships.
Mayur Gohil, MD of Zeta Analytical commented, "I am very excited for Zeta Analytical to join Phenna Group at an important time in my companies history. Our business has developed over many years, underpinned by strong family values and so selecting the right partner who appreciated and understood our operating model was important. Phenna and Zeta have a likeminded philosophy and that was key in my decision making.Since my first call with Paul and the Phenna Team, they have been easy to deal with, acting with integrity throughout. I believe the business is in great hands for the future ambitions we have. Zeta shares Phenna’s value of trust and allowing Zeta to operate with a high level of autonomy”.
Paul Barry, Group CEO of Phenna Group said, "I am pleased and excited to welcome Mayur and the wider Zeta team to Phenna Group. Zeta an excellent and experienced team and from our first meeting with Mayur, I was convinced they would be a great fit within our Group. Adding additional services and capacity to our Health Sciences Division has been a key strategic objective for the Group. I very much look forward to working with Mayur and his team to help deliver their ambitious growth plans.”
Phenna Group were advised by Johnston Carmichael and Avonhurst.
Zeta Analytical were advised by KBS Corporate Finance and Gateleys